These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 16445569)

  • 1. Inhibition of mitogen-activated protein kinase kinase enhances apoptosis induced by arsenic trioxide in human breast cancer MCF-7 cells.
    Ye J; Li A; Liu Q; Wang X; Zhou J
    Clin Exp Pharmacol Physiol; 2005 Dec; 32(12):1042-8. PubMed ID: 16445569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor growth inhibition by arsenic trioxide (As2O3) in the orthotopic metastasis model of androgen-independent prostate cancer.
    Maeda H; Hori S; Nishitoh H; Ichijo H; Ogawa O; Kakehi Y; Kakizuka A
    Cancer Res; 2001 Jul; 61(14):5432-40. PubMed ID: 11454688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
    Zhang YX; Kong CZ
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arsenic trioxide induces apoptosis through JNK and ERK in human mesothelioma cells.
    Eguchi R; Fujimori Y; Takeda H; Tabata C; Ohta T; Kuribayashi K; Fukuoka K; Nakano T
    J Cell Physiol; 2011 Mar; 226(3):762-8. PubMed ID: 20799280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination treatment with arsenic trioxide and sulindac enhances apoptotic cell death in lung cancer cells via activation of oxidative stress and mitogen-activated protein kinases.
    Park JH; Kim EJ; Jang HY; Shim H; Lee KK; Jo HJ; Kim HJ; Yang SH; Jeong ET; Kim HR
    Oncol Rep; 2008 Aug; 20(2):379-84. PubMed ID: 18636201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptosis induced by arsenic trioxide in leukemia U937 cells is dependent on activation of p38, inactivation of ERK and the Ca2+-dependent production of superoxide.
    Iwama K; Nakajo S; Aiuchi T; Nakaya K
    Int J Cancer; 2001 May; 92(4):518-26. PubMed ID: 11304686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitogen-activated protein/extracellular signal-regulated kinase kinase (MEK) inhibitors restore anoikis sensitivity in human breast cancer cell lines with a constitutively activated extracellular-regulated kinase (ERK) pathway.
    Fukazawa H; Noguchi K; Murakami Y; Uehara Y
    Mol Cancer Ther; 2002 Mar; 1(5):303-9. PubMed ID: 12489846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opposite effect of ERK1/2 and JNK on p53-independent p21WAF1/CIP1 activation involved in the arsenic trioxide-induced human epidermoid carcinoma A431 cellular cytotoxicity.
    Huang HS; Liu ZM; Ding L; Chang WC; Hsu PY; Wang SH; Chi CC; Chuang CH
    J Biomed Sci; 2006 Jan; 13(1):113-25. PubMed ID: 16283431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of JNK, p38 and ERK mitogen-activated protein kinases in the growth inhibition and apoptosis induced by cadmium.
    Chuang SM; Wang IC; Yang JL
    Carcinogenesis; 2000 Jul; 21(7):1423-32. PubMed ID: 10874022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MEK inhibition enhances paclitaxel-induced tumor apoptosis.
    MacKeigan JP; Collins TS; Ting JP
    J Biol Chem; 2000 Dec; 275(50):38953-6. PubMed ID: 11038347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrations.
    Zhu XH; Shen YL; Jing YK; Cai X; Jia PM; Huang Y; Tang W; Shi GY; Sun YP; Dai J; Wang ZY; Chen SJ; Zhang TD; Waxman S; Chen Z; Chen GQ
    J Natl Cancer Inst; 1999 May; 91(9):772-8. PubMed ID: 10328107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arsenic trioxide and breast cancer: analysis of the apoptotic, differentiative and immunomodulatory effects.
    Baj G; Arnulfo A; Deaglio S; Mallone R; Vigone A; De Cesaris MG; Surico N; Malavasi F; Ferrero E
    Breast Cancer Res Treat; 2002 May; 73(1):61-73. PubMed ID: 12083632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arsenic trioxide (ATO) and MEK1 inhibition synergize to induce apoptosis in acute promyelocytic leukemia cells.
    Lunghi P; Tabilio A; Lo-Coco F; Pelicci PG; Bonati A
    Leukemia; 2005 Feb; 19(2):234-44. PubMed ID: 15538402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged extracellular signal-regulated kinase 1/2 activation during fibroblast growth factor 1- or heregulin beta1-induced antiestrogen-resistant growth of breast cancer cells is resistant to mitogen-activated protein/extracellular regulated kinase kinase inhibitors.
    Thottassery JV; Sun Y; Westbrook L; Rentz SS; Manuvakhova M; Qu Z; Samuel S; Upshaw R; Cunningham A; Kern FG
    Cancer Res; 2004 Jul; 64(13):4637-47. PubMed ID: 15231676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of mitogen-activated protein kinase (MAPK) in troglitazone-induced osteoblastic cell death.
    Jung JY; Yoo CI; Kim HT; Kwon CH; Park JY; Kim YK
    Toxicology; 2007 May; 234(1-2):73-82. PubMed ID: 17363128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arsenic trioxide and melarsoprol induce apoptosis in plasma cell lines and in plasma cells from myeloma patients.
    Rousselot P; Labaume S; Marolleau JP; Larghero J; Noguera MH; Brouet JC; Fermand JP
    Cancer Res; 1999 Mar; 59(5):1041-8. PubMed ID: 10070961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitogen-activated protein kinase (MAPK) signalling pathways in HepG2 cells infected with a virulent strain of Klebsiella pneumoniae.
    Wu JH; Hong LC; Tsai YY; Chen HW; Chen WX; Wu TS
    Cell Microbiol; 2006 Sep; 8(9):1467-74. PubMed ID: 16922865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of p38 MAPK and JNK in Arsenic trioxide-induced mitochondrial cell death in human cervical cancer cells.
    Kang YH; Lee SJ
    J Cell Physiol; 2008 Oct; 217(1):23-33. PubMed ID: 18412143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of MEK-1/-2 signaling in monocytic and granulocytic differentiation of myeloid cell lines.
    Miranda MB; McGuire TF; Johnson DE
    Leukemia; 2002 Apr; 16(4):683-92. PubMed ID: 11960350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologic inhibitors of extracellular signal-regulated kinase (ERKs) and c-Jun NH(2)-terminal kinase (JNK) decrease glutathione content and sensitize human promonocytic leukemia cells to arsenic trioxide-induced apoptosis.
    Ramos AM; Fernandez C; Amrán D; Esteban D; de Blas E; Palacios MA; Aller P
    J Cell Physiol; 2006 Dec; 209(3):1006-15. PubMed ID: 16972261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.